NIST Advanced Technology Program
Return to ATP Home Page
Meet Our Staff Meet with ATP CLSO Staff In Your Area Search for an CLSO Funded Project New Directions E-mail comments Related Links CLSO Home Page
Genetic Manipulation in Animals:
ADVANCED TRANSGENESIS and CLONING
Participant's Name and Organization Title of Paper
Rosemarie Hunziker
Workshop Moderator

(formerly ATP/NIST)
Overview and Weekly Summary
Michael Bishop, et. al.
Infigen, Inc. and
Otto Postma
Pharming HealthCare
From Cell to Production
Ken Bondioli
Alexion Pharmaceuticals, Inc.
Technical Challenges of Cloning Pigs for BioMedical Research
Alan Colman
PPL Therapeutics
Somatic Cell Nuclear Transfer in Mammals
Jan Drayer
Chromos Molecular Systems
SATACs and Transgenesis
Neal First
University of Wisconsin at Madison
Concerns About Gene Transfer and Nuclear Transfer in Domestic Animals
Robert Gendron
Children's Hospital Medical Center, Cincinnati
Prospects and Hurdles in Optimizing the Vascular Support of Engineered Tissues
David Gottlieb
Washington University School of Medicine
ES Cells Make Neurons in a Dish
Alex Harvey
AviGenics, Inc.
Nuclear Transfer and Gene Targeting in Domestic Animals: Bioreactors of the Future
Robert J. Hawley and
Julia L. Greenstein
CellBio, Inc.
Application of Nuclear Transfer Technology in the Generation of Pigs for for Xenetransplantation
Peter Mountford
CellBio, Inc.
Genomics: Delivering Cell Culture Systems for Tissue Therapy
Roger Pedersen
University of California, San Francisco
Nuclear Transfer Technology
Jorge Piedrahita
Texas A&M University
Gene Targeting in Domestic Species: Challenges and Opportunities
Sushma Pati
Geoff Sargent and Mary E. Steven

Pangene Corporation
Homologous Recombination and Genetic Engineering of Transgenic Recombinant Animals
James Robl
University of Massachusetts at Amherst
Nuclear Transplantation in the Cow: Future Challenges
Steve Stice
Advanced Cell Technology, Inc.
Enhancing Transgenics through Cloning
Gregory Stock and
John Campbell
UCLA School of Medicine
Human Germline Engineering -- The Prospects for Commercial Development
H. Ralph Snodgrass
VistaGen, Inc.
Gorden Keller
National Jewish Medical & Research Center
ES Cells Offer is a Powerful Tool for Understanding the Genetic Control of Tissue Development and for Screening Potential Therapeutic Drugs
Jean-Micael Vos
University of North Carolina Medical Center
Mammalian Artificial Chromosomes for Animal Transgenesis
Mark Westhusin
Texas A&M University
Understanding Developmental Abnormalities in Offspring Produced by Nuclear Transplantation
Ian Wilmut
The Roslin Institute
Role of Cell Cycle
Xiangzhong (Jerry) Yang
University of Connecticut
Cloning and Other Reproductive Technologies for Application in Transgenics
Linda Yaswen-Corkery
Metamorphix, Inc.
Cell Culturing Technology as a Major Hurdle in the Commercialization of Genetically Altered Animals

Top


Return to
ATC's Main Page

Date created: October 1998
Last updated: April 12, 2005

Return to ATP Home Page ATP website comments: webmaster-atp@nist.gov   /  Technical ATP inquiries: InfoCoord.ATP@nist.gov.

NIST is an agency of the U.S. Commerce Department
Privacy policy / Security Notice / Accessibility Statement / Disclaimer / Freedom of Information Act (FOIA) /
No Fear Act Policy / NIST Information Quallity Standards / ExpectMore.gov (performance of federal programs)
Return to NIST Home Page
Return to ATP Home Page Return to NIST Home Page Go to NIST Home Page